Hypersensitivity pneumonitis in a patient with hypogammaglobulinemia.

J Allergy Clin Immunol

Allergy/Immunology Service, Fitzsimons Army Medical Center, Aurora, CO, USA.

Published: September 1996

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0091-6749(96)70108-2DOI Listing

Publication Analysis

Top Keywords

hypersensitivity pneumonitis
4
pneumonitis patient
4
patient hypogammaglobulinemia
4
hypersensitivity
1
patient
1
hypogammaglobulinemia
1

Similar Publications

Respiratory Diseases with High Occupational Fraction in Italy: Results from the Italian Hospital Discharge Registry (2010-2021).

Healthcare (Basel)

December 2024

Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian National Workers' Compensation Authority (INAIL), Via Stefano Gradi 55, 00143 Rome, Italy.

Objectives: Occupational respiratory diseases represent a major public health concern worldwide. This study analyses the hospitalization costs and characteristics of four major occupational respiratory diseases: malignant mesothelioma (MM), sinonasal cancer (SNC), pneumoconiosis (PN), and hypersensitivity pneumonitis (HP). The findings are situated within the context of Italy's population trends and healthcare system, offering insights into the economic and clinical burden of these diseases.

View Article and Find Full Text PDF

Clinical impact of pre-determined guideline selection for the diagnosis of fibrotic hypersensitivity pneumonitis.

Respir Med

December 2024

Pulmonology Department, Unidade Local de Saúde de São João, Alameda Professor Hernani Monteiro, 4200-319, Porto, Portugal; Faculty of Medicine, University of Porto, Alameda Professor Hernani Monteiro, 4200-319, Porto, Portugal.

Introduction And Objectives: International guidelines for the diagnosis of Hypersensitivity Pneumonitis (HP) have improved the diagnostic standardization of this heterogeneous interstitial lung disease. Our goal was to determine how the final multidisciplinary discussion confidence level for suspected fibrotic HP (fHP) can be impacted by the application of different guidelines validated in this context.

Materials And Methods: Retrospective study including patients submitted to transbronchial lung cryobiopsy (TBLC) with a final multidisciplinary meeting diagnosis of fHP.

View Article and Find Full Text PDF

Acute liver failure (ALF) is a rare, life-threatening condition that may be secondary to drug-induced liver injury (DILI) and certain viral infections. We present the case of a 73-year-old male with a history of fibrotic hypersensitivity pneumonitis with a progressive phenotype, type 2 diabetes mellitus, hypertension, and hyperlipidemia, who was admitted with ALF potentially secondary to DILI. Prior to admission, he was receiving therapy that may be related to idiosyncratic DILI (I-DILI) and ALF, namely nintedanib, which appears to have a most probable relation to I-DILI in this case, considering it was the most recently started drug.

View Article and Find Full Text PDF

Interventions to improve quality of life and knowledge in Hypersensitivity Pneumonitis, a survey of clinician practices and perspectives.

CHEST Pulm

December 2024

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.

Article Synopsis
  • The study explores the current practices and attitudes of interstitial lung disease (ILD) clinicians towards improving health-related quality of life (HRQOL) for patients with Hypersensitivity Pneumonitis (HP).
  • Nearly all respondents (100%) believe that interventions to enhance HRQOL are essential, but only 5% currently use validated HRQOL assessment tools.
  • Most clinicians reported limited knowledge of behavioral interventions, such as peer coaching and cognitive behavioral therapy (CBT), yet a significant majority expressed a desire to educate patients about these methods and reinforce them post-treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!